Impact of the Coronavirus Disease 2019 Pandemic on Substance Use Disorder Risk Among People Living With Human Immunodeficiency Virus (HIV) Enrolled in HIV Care in the United States: An Interrupted Time Series Analysis

The rising prevalence of SUD through late 2022 could be related to an increase in isolation and reduced access to substance use and HIV treatment caused by disruptions due to COVID-19. A renewed investment in integrated substance use treatment is vital to address the combined epidemics of substance use and HIV following the COVID-19 pandemic and to support resilience in the face of future disruptions.

Authors

Institutions

Publication Details

Journal
Open Forum Infectious Diseases
Published
2024-08-26
DOI
https://doi.org/10.1093/ofid/ofae491
Primary Topic
HIV, Drug Use, Sexual Risk
Type
article
Field-Weighted Citation Impact
0.00

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Impact of the Coronavirus Disease 2019 Pandemic on Substance Use Disorder Risk Among People Living With Human Immunodeficiency Virus (HIV) Enrolled in HIV Care in the United States: An Interrupted Time Series Analysis

Jennifer Jain, Matthew A. Spinelli, David V. Glidden, Monica Gandhi et al.
Open Forum Infectious Diseases
HIV, Drug Use, Sexual Risk
article

Impact of the Coronavirus Disease 2019 Pandemic on Substance Use Disorder Risk Among People Living With Human Immunodeficiency Virus (HIV) Enrolled in HIV Care in the United States: An Interrupted Time Series Analysis

Jennifer Jain, Matthew A. Spinelli, David V. Glidden, Monica Gandhi, Greer Burkholder, Kenneth Hugh Mayer, Megan J. Heise, Edward R. Cachay, Nadra E. Lisha, Jeffrey M. Jacobson, Carol Dawson‐Rose, Carlos Henrique Valente Moreira, Sonia Napravnik, Richard D. Moore, Mallory O. Johnson, Katerina A Christopoulos, Heidi M Crane
article en

Abstract

The rising prevalence of SUD through late 2022 could be related to an increase in isolation and reduced access to substance use and HIV treatment caused by disruptions due to COVID-19. A renewed investment in integrated substance use treatment is vital to address the combined epidemics of substance use and HIV following the COVID-19 pandemic and to support resilience in the face of future disruptions.

Open Forum Infectious DiseasesVol. 11(9)
University of North Carolina at Chapel Hill (US), Harvard University (US), Johns Hopkins University (US), University of California, San Francisco (US), University of Washington (US), University of Alabama at Birmingham (US), University of California San Diego (US), Case Western Reserve University (US)
National Institute of Mental Health, National Institute on Drug Abuse, National Institute of Allergy and Infectious Diseases
Good health and well-being
Openalex Percentile: Top 79%
HIV, Drug Use, Sexual Risk
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.